Who Attends? - 6th TPD Summit
A conference like no other… built with meticulously curated insight directly from you, the TPD industry’s biotech, academia and large pharma community, across all disciplines ranging from C-suite to computational sciences, from medicinal chemistry to CMC.
You told us what you needed to see to advance your degrader development pipelines and we listened.
Split Across 4 Distinct Tracks Based on the Stage of Drug Development You'll Find:
1. Target ID & Hit Validation: A-Alpha Bio, Monte Rosa Therapeutics, Orionis Biosciences, Structural Genomics Consortium, AbbVie, GSK
2. Lead Optimization: C4 Therapeutics, FIMECS, Plexium, Merck KGaA, Cullgen, Neomorph, Blueray Biopharma
3. Preclinical Development: Pfizer, Degron Therapeutics, Arvinas, Novartis, Proteovant Therapeutics, Astellas, 76Bio
4. Clinical Development: Nurix, FDA, AUTOTAC Bio, Hinova Pharmaceuticals, Kymera Therapeutics, Salarius Pharmaceuticals